Huaan France CAC40 ETF(QDII)

Sanofi Reaches Agreement with US Government to Lower Drug Costs and Promote Innovation

Sanofi Cuts Drug Prices and Plans to Upgrade Facilities in the US

Trump and multiple drug companies announce price cuts

Luisa Hector Maintains Buy Rating on Sanofi

TotalEnergies SE Subsidiary Saft Announces Progress in Space Battery Technology

TotalEnergies Shares Rise and Sell Greek Energy Assets

Sanofi's Aficamten Receives Marketing Approval in China

Sanofi's Efdoralprin alfa Drug Receives Orphan Drug Designation in the EU

Sanofi's drug Efdoralprin Alfa receives FDA Fast Track and Orphan Drug designation

TotalEnergies India Marketing and Energy Core Lanka Launch New Lubricant

TotalEnergies SE Signs Renewable Energy Agreement with Google for Malaysian Data Center

TotalEnergies SE Sells Partial Interest in Malaysia's SK408 Block

Adel Signs a $1.04 Billion Global License Agreement with Sanofi for Adel-Y01

ADEL, Inc. enters into a $1.04 billion global licensing agreement with Sanofi for Alzheimer's therapy

TotalEnergies SE completes 200 million euro share repurchase

Sanofi Announces Tolebrutinib Fails to Meet Expectations in Phase III Trials

Sanofi Expands Collaboration with Dren Bio to Develop Next-Generation B-Cell Depletion Therapies

U.S. Bank Securities Maintains Buy Rating on Sanofi

Sanofi Terminates Regulatory Pursuit of Tolebrutinib for PPMS

JPMorgan Analyst Maintains Hold Rating on Sanofi

SNYNF

Sanofi has reached an agreement with the US government to lower medicine costs while investing $20 billion to upgrade US facilities. The agreement includes a three-year tariff-free period for imports and offers medicines at 70% savings through TrumpRx.gov. Sanofi will reduce prices by an average of 61% for certain medicines in the US, without impacting its growth strategy or financial outlook during the agreement period.

Reuters

Sanofi

Sanofi Reaches Agreement With US Government To Lower Medicine Costs While Strengthening Innovation

AT LEAST SEVEN DRUG COMPANIES ARE SET TO ANNOUNCE PRICE CUTS WITH TRUMP AT WHITE HOUSE ON FRIDAY, INCLUDING GLAXOSMITHKLINE, MERCK AND SANOFI - WAPOSource:

Merck

At Least Seven Drug Companies Are Set To Announce Price Cuts With Trump At White House On Friday, Including Glaxosmithkline, Merck And Sanofi - Wapo

Berenberg Bank's Luisa Hector maintained a Buy rating for Sanofi with a price target of €105.00. Hector, who covers the Healthcare sector, has an average return of 6.3% and a 62.50% success rate. Deutsche Bank also rated Sanofi as Buy, while Kepler Capital maintained a Hold rating.

Tip Ranks

Berenberg Bank Sticks to Their Buy Rating for Sanofi (SNYNF)

TotalEnergies saw a 1% increase in stock value as European oil and gas stocks rose, driven by rising oil prices amid geopolitical tensions between the U.S. and Venezuela.1TotalEnergies participated in the sale of 10,000 tons of Eurobob E10 gasoline barges, collaborating with BP on the sell side, while Varo acted as the sole buyer.2

TradingView

TotalEnergies SE

Key facts: TotalEnergies stock rises 1%; sells 10,000 tons of gasoline

TotalEnergies SE, through its subsidiary Saft, has announced advancements in space battery technology, highlighting a 60-year history in satellite power. Saft pioneered lithium-ion batteries for satellites in the 1990s and has equipped around 1,500 satellites without causing failures. Saft is also involved in the ExoMars mission, set for 2028, with specially adapted batteries. This announcement underscores Saft's market leadership in satellite battery technology.

TotalEnergies Unveils Space-Ready Batteries with Proven Performance

TotalEnergies' stock rose about 1.5% as European energy stocks increased, following President Trump's blockade on oil tankers in Venezuela, raising concerns over potential supply disruptions.1TotalEnergies sold a 50% stake in a 424-MW wind and solar portfolio in Greece for 254 million euros, valuing it at 508 million euros. They will still operate the assets.23TotalEnergies traded 9,000 tons of Eurobob E10 gasoline barges, partnering with Trafigura, while BP and MB Energy were the buyers in this transaction.4

Key facts: TotalEnergies' stock rises; sells stake in Greek energy assets

Sanofi's Efdoralprin Alfa gained orphan status from the EMA for treating emphysema linked to Alpha-1 Antitrypsin Deficiency, meeting all Phase 2 study endpoints. Data will be presented soon.1Sanofi will pay $7.5 million to Cytokinetics following the approval of Myqorzo for obstructive hypertrophic cardiomyopathy in China, where Sanofi holds exclusive rights.2Sanofi has not accepted the most-favored-nation pricing for drugs, aligning with eleven other pharma firms, while Pfizer, Eli Lilly, AstraZeneca, Novo Nordisk, and EMD Serono have agreed.3

Key facts: Sanofi's Efdoralprin Alfa gains orphan status; $7.5M to Cytokinetics; rejects most-favored-nation pricing

TotalEnergies sold a 50% stake in its Greek wind and solar assets to Asterion Industrial Partners for 508 million euros ($595 million), valuing the assets at 1.2 million euros per megawatt. TotalEnergies retains the remaining stake and continues operations. This divestment is part of its strategy to optimize profitability and manage risk by divesting up to 50% of its renewable assets. TotalEnergies shares rose 1.90% to $65.06 in premarket trading.

benzinga_article

TotalEnergies Divests Half Of Greek Wind And Solar Assets For $595 Million

TotalEnergies Sells 50% Stake in Greek Renewables Portfolio for $595.4 Million

marketscreener

TotalEnergies Sells 50% Stake in Greek Renewables Portfolio for $595.4 Million

TotalEnergies has sold 50% of its 424-megawatt wind and solar portfolio in Greece to Asterion Industrial Partners for 254 million euros. The deal values the portfolio at 508 million euros. TotalEnergies will continue operating the assets and plans to sell electricity post-tariff expiration. The sale is part of efforts to reduce debt after acquisitions increased its debt-to-equity ratio.

TotalEnergies sells 50% of a Greek renewables portfolio for 254 million euros

TotalEnergies SE :SELLS 50% OF A 424 MW PORTFOLIO IN GREECETRANSACTION VALUES THE PORTFOLIO AT €508 MILLION, OR APPROXIMATELY €1.2 MILLION PER MW INSTALLEDTO PURCHASE AND MARKET MOST OF THE ELECTRICITY PRODUCED BY THESE ASSETS WHEN THEY NO LONGER BENEFIT FROM REGULATED TARIFFSSALE TO ASTERION INDUSTRIAL PARTNERSRETAINS A 50% STAKE AND REMAINS THE OPERATOR OF THE ASSETSSource for text: tinyurl.com/mwp2az7k

TotalEnergies Divests 50% Of 424 MW Portfolio In Greece

Sanofi SA will publish its Q4 and full year 2025 results on January 29, 2026, available on the company's website. The original content was published via GlobeNewswire on December 17, 2025.

Sanofi SA releases Q4 2025 Aide Memoire for investor guidance

Several major mergers and acquisitions were reported: Marsa Maroc acquired a 45% stake in Spain's BMT for €80 million; Kering sold a 60% stake in a New York property for $690 million; TotalEnergies sold a stake in a Malaysian gas block; ADNOC acquired a 95% stake in Covestro; Holcim bought a majority stake in Cementos Pacasmayo for $550 million; Kimmeridge Energy offered $6 billion for Ascent Resources; Citigroup sold a 25% stake in Banamex; WSP Global acquired TRC Companies for $3.3 billion.